Skip to main content

Table 5 Overview of experimental flow for the drug study. Conditions and task orders are further outlined in Table 6

From: Michigan Neural Distinctiveness (MiND) study protocol: investigating the scope, causes, and consequences of age-related neural dedifferentiation

  Drug Study
Timepoint: Enrolment Session 1 Session 2
Enrolment:
 Eligibility screen X   
 Informed consent X X  
 Condition Allocation X   
Intervention:
 Groups 1A & 1B Placebo   X  
 Groups 1A & 1B Lorazepam    X
 Groups 2A & 2B Placebo    X
 Groups 2A & 2B Lorazepam   X  
MRI:
 Groups 1A & 2A fMRI Tasks (visual-motor)   X  
 Groups 1A & 2A fMRI Tasks (motor-visual)    X
 Groups 1B & 2B fMRI Tasks (visual-motor)    X
 Groups 1B & 2B fMRI Tasks (motor-visual)   X  
 All Groups fMRI Resting State   X X